Sildenafil Pill Images

Drug Label Information
SC 100
Sildenafil Drug Class
5.8 Effects on Bleeding

Side Effect	Severity	Frequency	Comments
Headache	Common	Frequent	Usually mild
Flushing	Common	Frequent	Temporary, resolves quickly
Dyspepsia	Mild to moderate	Occasionally	Indigestion or upset stomach
Vision Changes	Rare	Infrequent	Bluish tint, increased light sensitivity
Priapism	Severe	Rare	Medical emergency

) Tj -281.05 -12 Td (For ) Tj 18.96 0 Td (current ) Tj 38.765 0 Td (labeling ) Tj 41.055 0 Td (information, ) Tj 61.25 0 Td (please ) Tj 34.707 0 Td (visit ) Tj 22.299 0 Td ( Tj ET endstream endobj 317 0 obj <>>>/Resources 321 0 R/Subtype/Form>>stream 0 g 0 G 0 i 0 J []0 d 0 j 1 w 10 M 0 Tc 0 Tw 100 Tz 0 TL 0 Tr 0 Ts BT /ArialRoundedMTBold 10 Tf 0 0 1 rg 0 -7.9 Td ( ) Tj ET endstream endobj 321 0 obj <> endobj 322 0 obj <> endobj 320 0 obj <>stream /This label may not be the latest approved by FDA. For current labeling information, please visit endstream endobj 319 0 obj <> endobj 323 0 obj <> endobj 318 0 obj <>stream /This label may not be the latest approved by FDA.

Drug Label Information

Given sildenafil peak plasm)8.5 (a concentrations of )]TJ 0.0008 Tc -0.0008 Tw -15.72 -1.23 Td [(approxim)8.6 (ately 1 )]TJ /C2_0 1 Tf 0 Tc 0 Tw <0050>Tj /TT0 1 Tf 0.0008 Tc -0.0008 Tw 7.355 0 Td [(M af)3.8 (ter recom)8.6 (m)8.6 (ended doses, it is unlikely that VIAGRA will alter the )]TJ 0.0007 Tc -0.0007 Tw -7.355 -1.165 Td [(clearance of substrates of these isoenzym)8.5 (es. )]TJ 0 Tc 0 Tw 0 -1.165 TD ( )Tj ET /Artifact <>BDC Q q 1 0 0 1 120.6970062 785.2004395 cm /GS1 gs /Fm0 Do Q EMC /Artifact <>BDC q 1 0 0 1 612 773.2004395 cm /GS1 gs /Fm1 Do Q EMC endstream endobj 316 0 obj <>>>/Resources 319 0 R/Subtype/Form>>stream 0 g 0 G 0 i 0 J []0 d 0 j 1 w 10 M 0 Tc 0 Tw 100 Tz 0 TL 0 Tr 0 Ts BT /ArialRoundedMTBold 10 Tf 0 0 1 rg 65.791 -7.9 Td (This ) Tj 22.92 0 Td (label ) Tj 26.055 0 Td (may ) Tj 22.71 0 Td (not ) Tj 18.12 0 Td (be ) Tj 14.692 0 Td (the ) Tj 18.023 0 Td (latest ) Tj 29.595 0 Td (approved ) Tj 48.974 0 Td (by ) Tj 14.17 0 Td (FDA. ) Tj -281.05 -12 Td (For ) Tj 18.96 0 Td (current ) Tj 38.765 0 Td (labeling ) Tj 41.055 0 Td (information, ) Tj 61.25 0 Td (please ) Tj 34.707 0 Td (visit ) Tj 22.299 0 Td ( Tj ET endstream endobj 317 0 obj <>>>/Resources 321 0 R/Subtype/Form>>stream 0 g 0 G 0 i 0 J []0 d 0 j 1 w 10 M 0 Tc 0 Tw 100 Tz 0 TL 0 Tr 0 Ts BT /ArialRoundedMTBold 10 Tf 0 0 1 rg 0 -7.9 Td ( ) Tj ET endstream endobj 321 0 obj <> endobj 322 0 obj <> endobj 320 0 obj <>stream /This label may not be the latest approved by FDA. For current labeling information, please visit endstream endobj 319 0 obj <> endobj 323 0 obj <> endobj 318 0 obj <>stream /This label may not be the latest approved by FDA. For current labeling information, please visit endstream endobj 315 0 obj <> endobj 310 0 obj <>stream q 1 0 0 1 -8.728516 -1.877228 cm 0 0 612 792 re W n 1 0 0 1 8.728516 1.877228 cm BT /GS0 gs /TT0 1 Tf 12 0 0 12 63.2715 47.6228 Tm ( )Tj 19 -0.005 Td (13)Tj 0.0007 Tc -0.0007 Tw -19 54.94 Td [(pectoris, dizziness, nausea\) upon initiation of sexua)-4 (l activity should be advised to refrain from)8.5 ( )]TJ 0.0008 Tc -0.0008 Tw 0 -1.165 TD (further activity and should discuss the episode with their physician.

Who should not take sildenafil?

)Tj 0 Tc 0 Tw T* ( )Tj 0.0008 Tc -0.0008 Tw T* (Physicians should advise patients to stop use )Tj 0.0003 Tc -0.0003 Tw (of all PDE5 inhibitors, including VIAGRA, and )Tj 0.0006 Tc -0.0006 Tw T* [(seek m)8.4 (e)-0.6 (dical attention in the event of a sudden loss of vision in one or both e\ yes. Such an event )]TJ 0.001 Tc -0.001 Tw T* [(m)8.8 (ay be a sign of non-arteritic anterior ischem)8.8 (ic)]TJ 0.0005 Tc -0.0005 Tw 18.99 0 Td ( optic neuropathy \(NAION\), a cause of decreased )Tj 0.0008 Tc -0.0008 Tw -18.99 -1.165 Td [(vision including perm)8.6 (anent loss of vision, that has been reported rarely post-m)8.6 (arketing in )]TJ T* [(tem)8.6 (poral association with the use of all PDE5 inhibitors. It is not possibl\ e to determ)8.6 (ine whether )]TJ 0.0009 Tc -0.0009 Tw T* (these events are related directly to the use of PD)Tj 0.0008 Tc -0.0008 Tw 19.335 0 Td (E5 inhibitors or to other factors. Physicians )Tj 0.0009 Tc -0.0009 Tw -19.335 -1.165 Td (should also discuss with patients the increased )Tj 0.0003 Tc -0.0003 Tw 18.84 0 Td (risk of NAION in individuals who have already )Tj 0.0005 Tc -0.0005 Tw -18.84 -1.165 Td (experienced NAION in one eye, including whether su)Tj 0.0006 Tc -0.0006 Tw 21.57 0 Td (ch individuals could be adversely affected )Tj -21.57 -1.18 Td (by use of vasodilators, such as PDE5 inhibitors \(see )Tj /TT1 1 Tf -0.0003 Tc 0 Tw 21.025 0 Td (POST-MARKETING )Tj 0.0003 Tw -21.025 -1.18 Td (EXPERIENCE/Special Senses)Tj /TT0 1 Tf 0.001 Tc 0 Tw 12.91 0 Td (\). )Tj 0 Tc -12.91 -1.165 Td ( )Tj 0.0008 Tc -0.0008 Tw T* (Physicians should advise patients to stop taki)Tj 0.0002 Tc -0.0002 Tw 18.09 0 Td (ng PDE5 inhibitors, including VIAGRA, and seek )Tj 0.0007 Tc -0.0007 Tw -18.09 -1.165 Td [(prom)8.5 (pt m)8.5 (edical attention in the event of sudden decrease or loss of hearing.

Other Medical Problems

Th\ ese events, which )]TJ 0.0008 Tc -0.0008 Tw T* [(m)8.6 (ay be accom)8.6 (p)0.8 (anied by tinnitus and dizziness, have been reported in tem)8.6 (poral association to the )]TJ 0.0006 Tc -0.0006 Tw T* [(intake of PDE5 inhibitors, including VIAGRA. It is not possible to deter\ m)8.4 (ine whether these )]TJ 0.0008 Tc -0.0008 Tw 0 -1.18 TD (events are related directly to the use of PDE5 inhibitors or to other fa\ ctors \(see )Tj /TT1 1 Tf -0.002 Tc 0 Tw 31.745 0 Td (ADVERSE )Tj 0.0003 Tc -0.0003 Tw -31.745 -1.18 Td (REACTIONS, Clinical Trials and Post-Marketing Experience)Tj /TT0 1 Tf 0.001 Tc 0 Tw 26.46 0 Td (\). )Tj /CS0 cs 1 0 0 scn 0 Tc -26.46 -1.165 Td ( )Tj 0 g 0.0007 Tc -0.0007 Tw 0 -1.165 TD (Physicians should warn patients that prolonged )Tj 0.0009 Tc -0.0009 Tw 19.14 0 Td [(erections greater than 4 hours and priapism)8.7 ( )]TJ 0.0008 Tc -0.0008 Tw -19.14 -1.165 Td [(\(painful erections greater than 6 hours in duration\))-4.3 ( have been reported infrequently since m)8.6 (arket )]TJ 0.0007 Tc -0.0007 Tw T* (approval of VIAGRA. In the event of an erection that persists longer tha\ n 150mg sildenafil for sale 4 hours, the patient )Tj 0.0009 Tc -0.0009 Tw T* [(should seek im)8.7 (m)8.7 (ediate m)8.7 (edical assistance. If pria)]TJ 0.001 Tc -0.001 Tw [(pism)8.8 ( is not treated im)8.8 (m)8.8 (ediately, penile tissue )]TJ 0.0007 Tc -0.0007 Tw T* [(dam)8.5 (age and perm)8.5 (anent loss of potency m)8.5 (ay result. For current labeling information, please visit endstream endobj 315 0 obj <> endobj 310 0 obj <>stream q 1 0 0 1 -8.728516 -1.877228 cm 0 0 612 792 re W n 1 0 0 1 8.728516 1.877228 cm BT /GS0 gs /TT0 1 Tf 12 0 0 12 63.2715 47.6228 Tm ( )Tj 19 -0.005 Td (13)Tj 0.0007 Tc -0.0007 Tw -19 54.94 Td [(pectoris, dizziness, nausea\) upon initiation of sexua)-4 (l activity should be advised to refrain from)8.5 ( )]TJ 0.0008 Tc -0.0008 Tw 0 -1.165 TD (further activity and should discuss the episode with their physician. )Tj 0 Tc 0 Tw T* ( )Tj 0.0008 Tc -0.0008 Tw T* (Physicians should advise patients to stop use )Tj 0.0003 Tc -0.0003 Tw (of all PDE5 inhibitors, including VIAGRA, and )Tj 0.0006 Tc -0.0006 Tw T* [(seek m)8.4 (e)-0.6 (dical attention in the event of a sudden loss of vision in one or both e\ yes. Such an event )]TJ 0.001 Tc -0.001 Tw T* [(m)8.8 (ay be a sign of non-arteritic anterior ischem)8.8 (ic)]TJ 0.0005 Tc -0.0005 Tw 18.99 0 Td ( optic neuropathy \(NAION\), a cause of decreased )Tj 0.0008 Tc -0.0008 Tw -18.99 -1.165 Td [(vision including perm)8.6 (anent loss of vision, that has been reported rarely post-m)8.6 (arketing in )]TJ T* [(tem)8.6 (poral association with the use of all PDE5 inhibitors. It is not possibl\ e to determ)8.6 (ine whether )]TJ 0.0009 Tc -0.0009 Tw T* (these events are related directly to the use of PD)Tj 0.0008 Tc -0.0008 Tw 19.335 0 Td (E5 inhibitors or to other factors.

Sildenafil white is a common name for the generic version of Viagra.
It is used to treat erectile dysfunction in men.
Sildenafil white is known for its rapid onset of action.
The medication works by enhancing blood flow to the penis.
It is typically taken about 30 to 60 minutes before sexual activity.
Sildenafil white is available in various doses, usually 25mg, 50mg, and 100mg.
The drug should not be used with nitrate medications to avoid dangerous interactions.
Common side effects include headache, flushing, and nasal congestion.
It is important to follow dosage instructions provided by a healthcare provider.
Sildenafil white can cause low blood pressure in some users.
Store sildenafil white in a cool, dry place, away from direct sunlight.

Physicians )Tj 0.0009 Tc -0.0009 Tw -19.335 -1.165 Td (should also discuss with patients the increased )Tj 0.0003 Tc -0.0003 Tw 18.84 0 Td (risk of NAION in individuals who have already )Tj 0.0005 Tc -0.0005 Tw -18.84 -1.165 Td (experienced NAION in one eye, including whether su)Tj 0.0006 Tc -0.0006 Tw 21.57 0 Td (ch individuals could be adversely affected )Tj -21.57 -1.18 Td (by use of vasodilators, such as PDE5 inhibitors \(see )Tj /TT1 1 Tf -0.0003 Tc 0 Tw 21.025 0 Td (POST-MARKETING )Tj 0.0003 Tw -21.025 -1.18 Td (EXPERIENCE/Special Senses)Tj /TT0 1 Tf 0.001 Tc 0 Tw 12.91 0 Td (\). )Tj 0 Tc -12.91 -1.165 Td ( )Tj 0.0008 Tc -0.0008 Tw T* (Physicians should advise patients to stop taki)Tj 0.0002 Tc -0.0002 Tw 18.09 0 Td (ng PDE5 inhibitors, including VIAGRA, and seek )Tj 0.0007 Tc -0.0007 Tw -18.09 -1.165 Td [(prom)8.5 (pt m)8.5 (edical attention in the event of sudden decrease or loss of hearing.

Product	Dosage	Quantity + Bonus	Price
Viagra Generic	25mg	180 + 6 Pills	154.93€ 147.55€
Viagra Generic	25mg	90 + 6 Pills	105.03€ 100.03€
Viagra Generic	100mg	270 + 10 Pills	270.47€ 257.59€
Kamagra Oral Jelly	100mg	110 + 9 Sachets	334.87€ 318.92€
Viagra Generic	200mg	60 + 4 Pills	125.19€ 119.23€
Viagra Generic	25mg	20 Pills	37.74€ 35.94€
Kamagra Oral Jelly	100mg	220 + 18 Sachets	662.24€ 630.70€
Viagra Generic	150mg	30 + 2 Pills	72.32€ 68.88€
Kamagra	100mg	20 Pills	86.09€ 81.99€
Viagra Generic	25mg	10 Pills	25.19€ 23.99€
Viagra Generic	200mg	120 + 8 Pills	204.80€ 195.05€

Sildenafil white was first approved by the FDA in 1998.
It is marketed under various brand and generic names worldwide.
The drug belongs to a class called phosphodiesterase inhibitors.
It is effective for many men with both physical and psychological ED.
Sildenafil white may also help treat pulmonary arterial hypertension.
Some users report experiencing visual disturbances after taking it.
The medication’s effects last approximately 4 to 6 hours.
It is advisable to avoid alcohol when taking sildenafil white.
Consumers should check for potential drug allergies before use.
The pill's color and shape can vary depending on the manufacturer.
Always consult a healthcare provider for appropriate use and dosing.

It is not possible to deter\ m)8.4 (ine whether these )]TJ 0.0008 Tc -0.0008 Tw 0 -1.18 TD (events are related directly to the use of PDE5 inhibitors or to other fa\ ctors \(see )Tj /TT1 1 Tf -0.002 Tc 0 Tw 31.745 0 Td (ADVERSE )Tj 0.0003 Tc -0.0003 Tw -31.745 -1.18 Td (REACTIONS, Clinical Trials and Post-Marketing Experience)Tj /TT0 1 Tf 0.001 Tc 0 Tw 26.46 0 Td (\). )Tj /CS0 cs 1 0 0 scn 0 Tc -26.46 -1.165 Td ( )Tj 0 g 0.0007 Tc -0.0007 Tw 0 -1.165 TD (Physicians should warn patients that prolonged )Tj 0.0009 Tc -0.0009 Tw 19.14 0 Td [(erections greater than 4 hours and priapism)8.7 ( )]TJ 0.0008 Tc -0.0008 Tw -19.14 -1.165 Td [(\(painful erections greater than 6 hours in duration\))-4.3 ( have been reported infrequently since m)8.6 (arket )]TJ 0.0007 Tc -0.0007 Tw T* (approval of VIAGRA.

Step	Description	Equipment Needed
Raw Material Preparation	Sourcing and testing chemical reagents	Reaction vessels, pH meters
Chemical Synthesis	Formation of sildenafil via chemical reactions	Reactors, stirring devices
Purification	Removing impurities through filtration or chromatography	Filtration units, chromatography columns
Tablet Compression	Forming pills from powder	Tablet press, molds
Packaging	Wrapping, labeling, and boxing	Packaging machines, labels

In the event of an erection that persists longer tha\ n 150mg sildenafil for sale 4 hours, the patient )Tj 0.0009 Tc -0.0009 Tw T* [(should seek im)8.7 (m)8.7 (ediate m)8.7 (edical assistance. If pria)]TJ 0.001 Tc -0.001 Tw [(pism)8.8 ( is not treated im)8.8 (m)8.8 (ediately, penile tissue )]TJ 0.0007 Tc -0.0007 Tw T* [(dam)8.5 (age and perm)8.5 (anent loss of potency m)8.5 (ay result. )]TJ 0 Tc 0 Tw T* ( )Tj 0.0005 Tc -0.0005 Tw T* [(The use of VIAGRA offers no protection against sexually transm)8.3 (itted diseases.

SC 100

Apcalis SX Jelly

Counseling of )]TJ 0.001 Tc -0.001 Tw T* [(patients about the protective m)8.8 (easures necessary to guard against sexually transm)8.8 (itted diseases, )]TJ 0.0005 Tc -0.0005 Tw T* [(including the Hum)8.3 (a)-0.7 (n Im)8.3 (m)8.3 (unodeficiency Virus \(HIV\), m)8.3 (a)-0.7 (y be considered. )]TJ 0 Tc 0 Tw T* ( )Tj /TT1 1 Tf 0.0004 Tc -0.0004 Tw 0 -1.18 TD (Drug Interactions )Tj 0.0002 Tc -0.0002 Tw 0 -1.17 TD (Effects of Other Drugs on VIAGRA )Tj /TT2 1 Tf 0.0009 Tc -0.0009 Tw T* (In vitro)Tj /TT1 1 Tf 0.0006 Tc -0.0006 Tw ( studies:)Tj /TT0 1 Tf 0.001 Tc -0.001 Tw 6.625 0 Td [( Sildenafil m)8.8 (etabolism)8.8 ( is principally )]TJ 0.0005 Tc -0.0005 Tw 14.82 0 Td [(m)8.3 (e)-0.7 (diated by the cytochrom)8.3 (e)-0.7 ( P450 \(CYP\) )]TJ 0.0006 Tc -0.0006 Tw -21.445 -1.165 Td [(isoform)8.4 (s 3A4 \(m)8.4 (ajor route\) and 2C9 \(m)8.4 (inor rout)-1.8 (e\).

Sildenafil white is often sold as small, round, white tablets.
It is available in various formulations, including sublingual and capsules.
The drug increases cGMP levels, leading to smooth muscle relaxation.
Generic sildenafil is usually cheaper than brand-name Viagra.
Erectile dysfunction can be caused by physical or mental health issues.
Misusing sildenafil white can result in priapism, a painful erection lasting hours.
Some formulations come with flavoring to improve taste.
Patient education about correct use is key to safety and effectiveness.
Sildenafil white does not protect against sexually transmitted infections.
It is important to avoid taking more than the recommended dose.
Long-term safety data is still being studied, but generally considered safe when used properly.

Therefore, inhibitors of these isoenzym)8.5 (es )]TJ 0.001 Tc -0.001 Tw 0 -1.165 TD [(m)8.8 (ay reduce sildenafil clearance. )]TJ 0 Tc 0 Tw T* ( )Tj /TT2 1 Tf 0.0008 Tc -0.0008 Tw 0 -1.18 TD (In vivo)Tj /TT1 1 Tf 0.0006 Tc -0.0006 Tw 2.865 0 Td ( studies:)Tj /TT0 1 Tf 3.535 0 Td [( Cim)8.5 (etidine \(800 m)8.5 (g)0.7 (\), a nonspecific CYP inhibitor, caused a 56% increase in )]TJ -6.4 -1.165 Td [(plasm)8.4 (a)-0.6 ( sildenafil concentrations when coadm)8.4 (i)-1.6 (nistered with VIAGRA \(50 m)8.4 (g)0.6 (\) to healthy )]TJ 0.0009 Tc 0 Tw 0 -1.165 TD (volunteers. )Tj 0 Tc T* ( )Tj 0.0001 Tc -0.0001 Tw T* [(W)8.9 (hen a single 100 m)7.9 (g dose of VIAGRA was adm)7.9 (i)]TJ 0.0008 Tc -0.0008 Tw 20.335 0 Td [(nistered with erythrom)8.6 (ycin, a specific )]TJ 0.0007 Tc -0.0007 Tw -20.335 -1.165 Td [(CYP3A4 inhibitor, at steady state \(500 m)8.5 (g)0.7 ( bid for 5 days\), there was a 182% increase in )]TJ T* [(sildenafil system)8.5 (ic exposure \(AUC\). In addition, in a study perform)8.5 (ed in healthy m)8.5 (ale )]TJ T* [(volunteers, coadm)8.5 (i)-1.5 (nistration of the HIV protease i)-1.1 (nhibitor saquinavir, also a CYP3A4 inhibitor, )]TJ T* [(at steady state \(1200 m)8.5 (g)0.7 ( tid\) with VIAGRA \(100 m)8.5 (g)0.7 ( single dose\) resulted in a 140% increase in )]TJ ET /Artifact <>BDC Q q 1 0 0 1 120.6970062 785.2004395 cm /GS1 gs /Fm0 Do Q EMC /Artifact <>BDC q 1 0 0 1 612 773.2004395 cm /GS1 gs /Fm1 Do Q EMC endstream endobj 312 0 obj <>>>/Resources 325 0 R/Subtype/Form>>stream 0 g 0 G 0 i 0 J []0 d 0 j 1 w 10 M 0 Tc 0 Tw 100 Tz 0 TL 0 Tr 0 Ts BT /ArialRoundedMTBold 10 Tf 0 0 1 rg 65.791 -7.9 Td (This ) Tj 22.92 0 Td (label ) Tj 26.055 0 Td (may ) Tj 22.71 0 Td (not ) Tj 18.12 0 Td (be ) Tj 14.692 0 Td (the ) Tj 18.023 0 Td (latest ) Tj 29.595 0 Td (approved ) Tj 48.974 0 Td (by ) Tj 14.17 0 Td (FDA. ) Tj -281.05 -12 Td (For ) Tj 18.96 0 Td (current ) Tj 38.765 0 Td (labeling ) Tj 41.055 0 Td (information, ) Tj 61.25 0 Td (please ) Tj 34.707 0 Td (visit ) Tj 22.299 0 Td ( Tj ET endstream endobj 313 0 obj <>>>/Resources 327 0 R/Subtype/Form>>stream 0 g 0 G 0 i 0 J []0 d 0 j 1 w 10 M 0 Tc 0 Tw 100 Tz 0 TL 0 Tr 0 Ts BT /ArialRoundedMTBold 10 Tf 0 0 1 rg 0 -7.9 Td ( ) Tj ET endstream endobj 327 0 obj <> endobj 328 0 obj <> endobj 326 0 obj <>stream /This label may not be the latest approved by FDA. For current labeling information, please visit endstream endobj 325 0 obj <> endobj 329 0 obj <> endobj 324 0 obj <>stream /This label may not be the latest approved by FDA. For current labeling information, please visit endstream endobj 311 0 obj <> endobj 306 0 obj <>stream q 1 0 0 1 -8.008606 -1.877228 cm 0 0 612 792 re W n 1 0 0 1 8.008606 1.877228 cm BT /GS0 gs /TT0 1 Tf 12 0 0 12 63.9914 47.6228 Tm ( )Tj 19 -0.005 Td (12)Tj 0.0008 Tc -0.0008 Tw -19 54.94 Td [(- In those patients already taking an optim)8.6 (ized dose of a PDE5 inhibitor, alpha-blocker therapy )]TJ 0 -1.165 TD [(should be initiated at the lowest dose.

Sildenafil Drug Class

)]TJ 0 Tc 0 Tw T* ( )Tj 0.0005 Tc -0.0005 Tw T* [(The use of VIAGRA offers no protection against sexually transm)8.3 (itted diseases. Counseling of )]TJ 0.001 Tc -0.001 Tw T* [(patients about the protective m)8.8 (easures necessary to guard against sexually transm)8.8 (itted diseases, )]TJ 0.0005 Tc -0.0005 Tw T* [(including the Hum)8.3 (a)-0.7 (n Im)8.3 (m)8.3 (unodeficiency Virus \(HIV\), m)8.3 (a)-0.7 (y be considered. )]TJ 0 Tc 0 Tw T* ( )Tj /TT1 1 Tf 0.0004 Tc -0.0004 Tw 0 -1.18 TD (Drug Interactions )Tj 0.0002 Tc -0.0002 Tw 0 -1.17 TD (Effects of Other Drugs on VIAGRA )Tj /TT2 1 Tf 0.0009 Tc -0.0009 Tw T* (In vitro)Tj /TT1 1 Tf 0.0006 Tc -0.0006 Tw ( studies:)Tj /TT0 1 Tf 0.001 Tc -0.001 Tw 6.625 0 Td [( Sildenafil m)8.8 (etabolism)8.8 ( is principally )]TJ 0.0005 Tc -0.0005 Tw 14.82 0 Td [(m)8.3 (e)-0.7 (diated by the cytochrom)8.3 (e)-0.7 ( P450 \(CYP\) )]TJ 0.0006 Tc -0.0006 Tw -21.445 -1.165 Td [(isoform)8.4 (s 3A4 \(m)8.4 (ajor route\) and 2C9 \(m)8.4 (inor rout)-1.8 (e\). Therefore, inhibitors of these isoenzym)8.5 (es )]TJ 0.001 Tc -0.001 Tw 0 -1.165 TD [(m)8.8 (ay reduce sildenafil clearance. )]TJ 0 Tc 0 Tw T* ( )Tj /TT2 1 Tf 0.0008 Tc -0.0008 Tw 0 -1.18 TD (In vivo)Tj /TT1 1 Tf 0.0006 Tc -0.0006 Tw 2.865 0 Td ( studies:)Tj /TT0 1 Tf 3.535 0 Td [( Cim)8.5 (etidine \(800 m)8.5 (g)0.7 (\), a nonspecific CYP inhibitor, caused a 56% increase in )]TJ -6.4 -1.165 Td [(plasm)8.4 (a)-0.6 ( sildenafil concentrations when coadm)8.4 (i)-1.6 (nistered with VIAGRA \(50 m)8.4 (g)0.6 (\) to healthy )]TJ 0.0009 Tc 0 Tw 0 -1.165 TD (volunteers.

Dosage for erectile dysfunction (ED)

)Tj 0 Tc T* ( )Tj 0.0001 Tc -0.0001 Tw T* [(W)8.9 (hen a single 100 m)7.9 (g dose of VIAGRA was adm)7.9 (i)]TJ 0.0008 Tc -0.0008 Tw 20.335 0 Td [(nistered with erythrom)8.6 (ycin, a specific )]TJ 0.0007 Tc -0.0007 Tw -20.335 -1.165 Td [(CYP3A4 inhibitor, at steady state \(500 m)8.5 (g)0.7 ( bid for 5 days\), there was a 182% increase in )]TJ T* [(sildenafil system)8.5 (ic exposure \(AUC\). In addition, in a study perform)8.5 (ed in healthy m)8.5 (ale )]TJ T* [(volunteers, coadm)8.5 (i)-1.5 (nistration of the HIV protease i)-1.1 (nhibitor saquinavir, also a CYP3A4 inhibitor, )]TJ T* [(at steady state \(1200 m)8.5 (g)0.7 ( tid\) with VIAGRA \(100 m)8.5 (g)0.7 ( single dose\) resulted in a 140% increase in )]TJ ET /Artifact <>BDC Q q 1 0 0 1 120.6970062 785.2004395 cm /GS1 gs /Fm0 Do Q EMC /Artifact <>BDC q 1 0 0 1 612 773.2004395 cm /GS1 gs /Fm1 Do Q EMC endstream endobj 312 0 obj <>>>/Resources 325 0 R/Subtype/Form>>stream 0 g 0 G 0 i 0 J []0 d 0 j 1 w 10 M 0 Tc 0 Tw 100 Tz 0 TL 0 Tr 0 Ts BT /ArialRoundedMTBold 10 Tf 0 0 1 rg 65.791 -7.9 Td (This ) Tj 22.92 0 Td (label ) Tj 26.055 0 Td (may ) Tj 22.71 0 Td (not ) Tj 18.12 0 Td (be ) Tj 14.692 0 Td (the ) Tj 18.023 0 Td (latest ) Tj 29.595 0 Td (approved ) Tj 48.974 0 Td (by ) Tj 14.17 0 Td (FDA. ) Tj -281.05 -12 Td (For ) Tj 18.96 0 Td (current ) Tj 38.765 0 Td (labeling ) Tj 41.055 0 Td (information, ) Tj 61.25 0 Td (please ) Tj 34.707 0 Td (visit ) Tj 22.299 0 Td ( Tj ET endstream endobj 313 0 obj <>>>/Resources 327 0 R/Subtype/Form>>stream 0 g 0 G 0 i 0 J []0 d 0 j 1 w 10 M 0 Tc 0 Tw 100 Tz 0 TL 0 Tr 0 Ts BT /ArialRoundedMTBold 10 Tf 0 0 1 rg 0 -7.9 Td ( ) Tj ET endstream endobj 327 0 obj <> endobj 328 0 obj <> endobj 326 0 obj <>stream /This label may not be the latest approved by FDA. For current labeling information, please visit endstream endobj 325 0 obj <> endobj 329 0 obj <> endobj 324 0 obj <>stream /This label may not be the latest approved by FDA. For current labeling information, please visit endstream endobj 311 0 obj <> endobj 306 0 obj <>stream q 1 0 0 1 -8.008606 -1.877228 cm 0 0 612 792 re W n 1 0 0 1 8.008606 1.877228 cm BT /GS0 gs /TT0 1 Tf 12 0 0 12 63.9914 47.6228 Tm ( )Tj 19 -0.005 Td (12)Tj 0.0008 Tc -0.0008 Tw -19 54.94 Td [(- In those patients already taking an optim)8.6 (ized dose of a PDE5 inhibitor, alpha-blocker therapy )]TJ 0 -1.165 TD [(should be initiated at the lowest dose.

How should I store sildenafil?

Stepwise increase in alpha-block\ er dose m)8.6 (ay be associated )]TJ 0.0005 Tc -0.0005 Tw T* (with further lowering of blood pressure when taking a PDE5 inhibitor. )Tj T* [(- Safety of com)8.3 (b)0.5 (ined use of PDE5 inhibitors and alpha-blockers m)8.3 (a)-0.7 (y be affected by other )]TJ 0.0009 Tc -0.0009 Tw T* [(variables, including intravascular volum)8.7 (e depletion and other anti-hypertensive drugs. )]TJ 0 Tc 0 Tw T* ( )Tj 0.0007 Tc -0.0007 Tw T* [(Viagra has system)8.5 (ic vasodilatory properties and m)8.5 (ay augm)8.5 (ent the blood pressure lowering effect )]TJ 0.0009 Tc -0.0009 Tw T* [(of other anti-hypertensive m)8.7 (edications. Stepwise increase in alpha-block\ er dose m)8.6 (ay be associated )]TJ 0.0005 Tc -0.0005 Tw T* (with further lowering of blood pressure when taking a PDE5 inhibitor. )Tj T* [(- Safety of com)8.3 (b)0.5 (ined use of PDE5 inhibitors and alpha-blockers m)8.3 (a)-0.7 (y be affected by other )]TJ 0.0009 Tc -0.0009 Tw T* [(variables, including intravascular volum)8.7 (e depletion and other anti-hypertensive drugs.

5.8 Effects on Bleeding

)]TJ 0 Tc 0 Tw T* ( )Tj 0.0007 Tc -0.0007 Tw T* [(Viagra has system)8.5 (ic vasodilatory properties and m)8.5 (ay augm)8.5 (ent the blood pressure lowering effect )]TJ 0.0009 Tc -0.0009 Tw T* [(of other anti-hypertensive m)8.7 (edications.

ALS Guidance

Live your life until you can't